Log In
BCIQ
Print this Print this
 

etripamil (MSP-2017)

  Manage Alerts
Collapse Summary General Information
Company Milestone Pharmaceuticals Inc.
DescriptionCalcium channel antagonist
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationTachycardia
Indication DetailsTreat paroxysmal supraventricular tachycardia (PSVT)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today